Mumbai, Maharashtra, India True North appeared to be the Corporate Investor, which was created in 2015. The leading representative office of defined Corporate Investor is situated in the San Francisco. The venture was found in North America in United States.
This organization was formed by Brian Samson. We also calculated 2 valuable employees in our database.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the True North, startups are often financed by Chrys Capital, ePlanet Capital, Sequoia Capital India. The meaningful sponsors for the fund in investment in the same round are LeapFrog Investments, Tata Opportunities Fund (TOF), TA Associates. In the next rounds fund is usually obtained by Matrix Partners India, Capier Investments, Brand Capital.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The average startup value when the investment from True North is more than 1 billion dollars. The top amount of exits for fund were in 2003. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2019.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - India. The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Fincare, Cloudnine Hospitals, Trivitron Healthcare.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Immuneel Therapeutics | $15M | 21 Jun 2022 | Bengaluru, Karnataka, India | ||
Cloudnine Hospitals | $60M | 24 Dec 2015 | India, Karnataka |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Immuneel Therapeutics | $15M | 21 Jun 2022 | Bengaluru, Karnataka, India | ||
Cloudnine Hospitals | $60M | 24 Dec 2015 | India, Karnataka |
